why choose us

First received: October 26, 2022

Clinical Trial: Methimazole in Patients With Progressive Glioblastoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Glioblastoma

Study Type: INTERVENTIONAL


Official Title: Targeting Transsulfuration Via Suppression of Thyroid Hormone Signaling in Progressive Glioblastoma: Phase 2 and Pharmacodynamic Trial of Methimazole in Patients With Progressive Glioblastoma

Brief Summary: The purpose of this study is to test the effectiveness, safety, and tolerability of a drug called Methimazole.The investigational drug, Methimazole is not FDA approved for brain tumors, but it is used to treat thyroid illnesses.Different doses of Methimazole will be given to several study participants with glioblastoma.The first several study participants will receive the lowest dose.If the drug does not cause serious side effects, it will be given to other study participants at a higher dose.The doses will…

Read more